Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes [NA]

View source ↗

Summary

A Dana-Farber Cancer Institute trial is evaluating whole-body MRI screening to detect primary tumors in children and adults with Li-Fraumeni Syndrome and other …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Li-Fraumeni Syndrome | NA | Status: ACTIVE_NOT_RECRUITING